Detalles de la búsqueda
1.
NTCP modelling of lung toxicity after SBRT comparing the universal survival curve and the linear quadratic model for fractionation correction.
Acta Oncol
; 50(4): 518-27, 2011 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-21198416
2.
Stereotactic body radiotherapy for medically inoperable patients with stage I non-small cell lung cancer - a first report of toxicity related to COPD/CVD in a non-randomized prospective phase II study.
Radiother Oncol
; 88(3): 359-67, 2008 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-18768228
3.
Multicentre phase II trial of paclitaxel and carboplatin with concurrent radiotherapy in locally advanced non-small cell lung cancer.
Anticancer Res
; 28(5B): 2851-7, 2008.
Artículo
en Inglés
| MEDLINE | ID: mdl-19031924
4.
Phase III trial of gemcitabine plus carboplatin versus single-agent gemcitabine in the treatment of locally advanced or metastatic non-small-cell lung cancer: the Swedish Lung Cancer Study Group.
J Clin Oncol
; 23(33): 8380-8, 2005 Nov 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-16293868
5.
Gemcitabine versus gemcitabine/carboplatin in advanced non-small cell lung cancer: preliminary findings in a phase III trial of the Swedish Lung Cancer Study Group.
Semin Oncol
; 29(3 Suppl 9): 50-4, 2002 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-12094340
6.
A randomised phase II study of pemetrexed versus pemetrexed+erlotinib as second-line treatment for locally advanced or metastatic non-squamous non-small cell lung cancer.
Eur J Cancer
; 50(9): 1571-80, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24703574
7.
Predictive role of plasma vascular endothelial growth factor for the effect of celecoxib in advanced non-small cell lung cancer treated with chemotherapy.
Eur J Cancer
; 49(1): 115-20, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22951014
8.
Randomized phase II study of gemcitabine and carboplatin +/- sequential docetaxel in non-small cell lung cancer.
Lung Cancer
; 71(2): 178-81, 2011 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-20546968
9.
Effect of celecoxib on survival in patients with advanced non-small cell lung cancer: a double blind randomised clinical phase III trial (CYCLUS study) by the Swedish Lung Cancer Study Group.
Eur J Cancer
; 47(10): 1546-55, 2011 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-21565487
10.
Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy.
J Clin Oncol
; 27(20): 3290-6, 2009 Jul 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-19414667
11.
Irinotecan plus carboplatin versus oral etoposide plus carboplatin in extensive small-cell lung cancer: a randomized phase III trial.
J Clin Oncol
; 26(26): 4261-7, 2008 Sep 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-18779613
Resultados
1 -
11
de 11
1
Próxima >
>>